JANE STREET GROUP, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 156 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$421,256
-38.8%
163,913
+17.2%
0.00%
Q1 2024$688,313
+36.9%
139,901
+144.6%
0.00%
Q4 2023$502,656
-70.2%
57,185
-61.1%
0.00%
-100.0%
Q3 2023$1,685,883
-40.5%
146,982
+31.2%
0.00%0.0%
Q2 2023$2,834,391
-68.0%
111,987
-59.2%
0.00%
-75.0%
Q1 2023$8,851,276
+1777.1%
274,799
+975.8%
0.00%
Q4 2022$471,542
-92.9%
25,544
-89.7%
0.00%
-100.0%
Q3 2022$6,671,000
+1095.5%
247,065
+512.1%
0.00%
Q2 2022$558,000
-91.0%
40,363
-87.2%
0.00%
-100.0%
Q1 2022$6,168,000
+152.1%
316,336
+111.0%
0.00%
Q4 2021$2,447,000
+59.8%
149,900
+172.7%
0.00%
Q3 2021$1,531,000
-35.3%
54,961
-31.1%
0.00%
-100.0%
Q2 2021$2,366,000
-15.0%
79,800
-19.9%
0.00%0.0%
Q1 2021$2,784,000
+7.7%
99,600
+9.1%
0.00%0.0%
Q4 2020$2,586,000
+153.0%
91,255
+124.6%
0.00%
Q3 2020$1,022,000
+223.4%
40,632
+102.9%
0.00%
-100.0%
Q1 2019$316,000
+15.3%
20,029
+47.4%
0.00%0.0%
Q4 2018$274,000
-60.0%
13,588
-29.1%
0.00%
-50.0%
Q4 2017$685,000
+190.3%
19,172
+177.9%
0.00%
+100.0%
Q4 2015$236,0006,9000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
NQ HCIF GP, Ltd. 3,096,650$52,457,000100.00%
Essex Woodlands Management, Inc. 4,592,047$77,789,00024.28%
Rhenman & Partners Asset Management AB 126,574$2,144,0000.62%
Polar Capital LLP 1,107,272$18,756,0000.37%
ArrowMark Colorado Holdings LLC 787,923$13,347,0000.34%
Lombard Odier Asset Management (USA) Corp 250,605$4,245,0000.29%
Visium Asset Management, LP 1,000,000$16,940,0000.24%
C Partners Holding GmbH 24,000$407,0000.13%
NOTTINGHAM ADVISORS, INC. 23,018$390,0000.10%
WALL STREET ASSOCIATES 57,330$971,0000.09%
View complete list of REVANCE THERAPEUTICS INC shareholders